Selank's benefits include potential support for anxiety regulation, stress resilience, cognitive function, and neurological health, thus attracting growing interest from both the scientific community and individuals following research peptide developments. Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the naturally occurring immunological peptide tuftsin. Developed in Russia, it has been investigated for its potential anxiolytic, nootropic, neuroprotective, and immunomodulatory properties. Unlike many traditional anxiolytic drugs that primarily act on a single neurotransmitter system, Selank appears to influence multiple pathways related to mood, cognitive functions, stress adaptation, and brain function, including GABA signalling, endogenous opioid peptides, neurotrophic factors, and immune system mediators [1–3].
Research suggests that the combination of these mechanisms may support emotional balance, cognitive function, stress resilience, and neurological health without causing significant sedation or risk of addiction [1-3].
To get basic information about this peptide, it is also worth familiarising yourself with the main guide: https://bioevidencehub.com/peptyd-selank/.
Selank and Anxiety
Anxiety regulation is the best-studied area of Selank research. In a clinical trial involving 62 patients with general anxiety disorder (GAD) and neurasthenia, Selank was shown to exert an anxiolytic effect comparable to the benzodiazepine medazepam. In addition to reducing anxiety symptoms, anti-asthenic and psychostimulant effects were also observed, helping participants maintain mental performance and daily activity [4].
Laboratory studies suggest that Selank may influence anxiety regulation by acting as a positive allosteric modulator of GABA receptors. This mechanism is somewhat similar to the action of classic anxiolytic drugs, however, Selank appears to interact with the GABA system more selectively, which may explain its tranquillising effect without marked sedation [1].
Animal studies further corroborate these observations. Researchers have demonstrated that Selank strengthened the anxiolytic effects of benzodiazepines while reducing some of their sedative and muscle-relaxant properties [5].
Selank and Stress Resistance
Chronic stress can disrupt neurotransmitter balance, immune system function, emotional regulation, and neuroplasticity. Several studies suggest that Selank may support the body in adapting to stress by influencing multiple biological systems involved in the stress response [1,2].
One of the proposed mechanisms is the protection of enkephalins – naturally occurring opioid peptides that play a significant role in mood regulation and stress adaptation. Researchers have demonstrated that Selank effectively inhibits enzymes responsible for enkephalin breakdown and exhibits stronger activity than some reference compounds used in laboratory studies [6].
By maintaining the activity of endogenous enkephalins, Selank may support emotional stability and mental resilience during periods of increased stress.
Selank as a Nootropic
Beyond its anxiolytic properties, Selank has garnered interest as a potential nootropic peptide. Research suggests that it may support learning, memory, cognitive efficiency, and mental acuity, particularly in situations where stress or anxiety negatively impact cognitive function [1,2].
Unlike stimulants that primarily work by increasing catecholamine release, Selank appears to interact with broader regulatory systems related to neural communication, adaptation, and neuroplasticity. For this reason, it is being studied as a peptide that supports cognitive functions while maintaining neurochemical balance [2,3].
Selank and Cognitive Functions
Several studies suggest that Selank may affect memory processes, information processing, and the ability of neurons to adapt by interacting with neurotrophic factors and cell signalling pathways.
In one study concerning the intranasal administration of Selank in rats, significant alterations in the expression of brain-derived neurotrophic factor (BDNF) were observed in the hippocampus. Given that BDNF plays a crucial role in learning, memory consolidation, synaptic plasticity, and long-term brain health, these findings may partially explain Selank's effects on cognitive functions [7].
Further transcriptomic studies of Selank-related peptides have shown changes in the expression of genes associated with immune regulation, cell signalling and neuronal adaptation after neurological damage [8].
Selank and Concentration
Many people are interested in Selank due to its potential to support concentration and mental productivity. Although there are few direct clinical studies assessing attention and focus, several mechanisms can explain such an effect.
Anxiety often impairs executive functions, working memory, and the ability to sustain attention. By supporting anxiety regulation without overt sedative action, Selank may enable more efficient use of cognitive resources during task performance. The psychostimulant and anti-asthenic effects observed in clinical studies also support this hypothesis [4].
Selank ADHD
Interest in Selank in the context of ADHD stems mainly from reports concerning its effects on attention, emotional regulation, and cognitive functions. However, there are currently no large clinical trials assessing Selank as a treatment for ADHD.
Researchers suggest that Selank's influence on neurotransmitter systems involved in attention and executive functions may partially explain the observed effects. However, further controlled studies are needed to draw definitive conclusions [1–3].
Selank and Dopamine
Dopamine plays a significant role in motivation, reward, focus, and cognitive function. Research suggests that Selank might indirectly influence dopaminergic signalling through broader neurochemical regulation and neuropeptide activity.
Instead of acting as a direct dopamine receptor agonist, Selank appears to function as a regulatory peptide concurrently affecting multiple neurotransmitter systems. This mechanism may support mood, motivation, cognitive function, and emotional stability without overstimulation [1,2].
Selank and Serotonin
Serotonin plays a part in mood regulation, anxiety control, emotional processing, and overall mental well-being. While Selank's most well-known mechanism remains modulation of the GABA system, researchers believe its broader neuroregulatory effects may also influence serotonin-related pathways.
These interactions may partly explain the improvement in mood and emotional balance observed in experimental and clinical studies [1,2].
Selank and BDNF
One of the most interesting discoveries concerning Selank is its effect on brain-derived neurotrophic factor (BDNF). BDNF is essential for neuronal growth, synaptic plasticity, learning processes, memory formation, and neuroprotection.
In experimental studies using intranasal administration, Selank was observed to regulate BDNF gene expression in the hippocampus. Given that reduced BDNF activity is associated with stress, cognitive impairment, and limited neuroplasticity, this discovery has generated significant interest in the potential impact of Selank on long-term brain health [7].
Selank and Cortisol
Cortisol is one of the main stress hormones. Elevated cortisol levels are often associated with increased anxiety, poorer cognitive function, sleep problems, and reduced stress resilience.
There are few direct studies evaluating the effect of Selank on cortisol levels; however, its documented influence on anxiety regulation, GABA activity, endogenous opioid peptides, and stress adaptation mechanisms suggests it may indirectly affect the body's stress response [1,2,6].
Selank and Sen
Sleep quality plays a crucial role in cognitive functions, emotional regulation, and the regeneration of the nervous system. Scientific reviews concerning Selank and related neuroregulatory peptides indicate potential benefits related to stress reduction and support for nervous system balance, which may indirectly influence sleep quality [2].
By supporting emotional stability and reducing anxiety, Selank may create conditions conducive to restorative sleep. However, unlike classic sleeping pills, it does not appear to act primarily as a soporific [1,4].
Neuroprotective Properties of Selank
Research suggests that Selank possesses neuroprotective properties that extend beyond simply supporting anxiety regulation. Experimental studies have demonstrated effects on neurotrophic factors, immune signalling pathways, gene expression, and neuronal adaptation mechanisms.
The Pro-Gly-Pro fragment present in the Selank molecule may also contribute its own neuroprotective activity. Researchers suggest that this element not only increases the stability of the peptide but may also participate in neuron protection and regeneration processes [8,9].
Immunological and Antiviral Activity
As Selank was developed from tuftsin – a natural immunomodulating peptide – researchers also analysed its effects on the functioning of the immune system.
Experimental studies have demonstrated antiviral activity against several viral models and the ability of Selank-related peptides to stimulate interferon production. Further analyses have identified specific structural fragments responsible for antiviral activity, suggesting that Selank's effects may extend beyond the nervous system [10].
Does Selank Actually Work?
Current scientific data indicates that Selank elicits measurable biological effects in both human and animal studies. Clinical trials have demonstrated anxiolytic effects comparable to some commonly used medications, while mechanistic studies have confirmed its influence on GABA signalling, endogenous opioid peptide metabolism, neurotrophic factors, the immune system, and gene expression [1,4,6,7].
However, it should be noted that most of the research originates from Russia and Eastern Europe, and large international clinical trials are still lacking. Although the current findings are promising, further randomised controlled trials are needed.
Summary
Research suggests that Selank may support anxiety regulation, stress resilience, cognitive function, emotional balance, neuroprotection, and overall brain health through a variety of biological mechanisms. Its action appears to involve GABAergic signalling, endogenous opioid peptide pathways, neurotrophic factors such as BDNF, immune regulation, and broader neurochemical modulation.
Despite promising results, further large-scale clinical trials are needed to fully assess Selank's therapeutic potential, its optimal uses, and its safety profile.
Disclaimer
This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Selank is not approved as a treatment for anxiety disorders, cognitive problems, ADHD, sleep disorders, or other conditions in many countries. Human trials are still limited, and further clinical studies are necessary to fully assess its safety and efficacy.
For research purposes only: Selank products supplied by Semax Polska are intended solely for laboratory and scientific research. They are not intended for human consumption or for medical, diagnostic, therapeutic or prophylactic use. Researchers should use them in accordance with applicable laws, regulations and scientific research standards.
References
[1] Vyunova, T. V., Andreeva, L. N., Shevchenko, K. V., & Myasoedov, N. F. (2018). Peptide-based anxiolytics: The molecular aspects of heptapeptide Selank biological activity. Protein and Peptide Letters, 25(10), 914-923. https://doi.org/10.2174/0929866525666180925144642
[2] Frontiers in Pharmacology. (2016). Mechanisms of action and neurobiological effects of Selank and related regulatory peptides. Frontiers in Pharmacology, 7, Article 31. https://doi.org/10.3389/fphar.2016.00031
[3] PubChem. (2026). Selank (CID 11765600). National Centre for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/Selank
[4] Zozulia, A. A., Neznamov, G. G., Syuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebryakova, E. V., Siranchieva, O. A., Andryushchenko, A. V., Telesheva, E. S., Syuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalised anxiety disorders and neurasthenia. Journal of Neurology and Psychiatry named after S. S. Korsakov, 108(4), 38-48. https://pubmed.ncbi.nlm.nih.gov/18454096/
[5] Kost, N. V., Sokolov, O. Y., Zozulya, S. A., & Myasoedov, N. F. (2025). Combined action of benzodiazepine tranquillisers and the peptide anxiolytic Selank in BALB/c mice. Neurochemical Journal, 19, 743–748. https://doi.org/10.1134/S1819712425700783
[6] Zozulya, A. A., Kost, N. V., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. N., Zolotarev, Y. A., Ivanov, S. V., Andryushchenko, A. V., Myasoedov, N. F., & Smulevich, A. B. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine, 131(4), 315-317. https://doi.org/10.1023/A:1017979514274
[7] Levitskaya, N. G., Andreeva, L. A., Nagaev, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 431, 79–82. https://www.researchgate.net/publication/23306196_Intranasal_administration_of_the_peptide_Selank_regulates_BDNF_expression_in_the_rat_hippocampus_in_vivo
[8] Medvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborskaia, S. A., Skvortsova, V. I., Miasoedov, N. F., & Dergunova, L. V. (2014). Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischaemia. Molecular Biology (Moscow), 48(2), 277–287. PMID: 25850296.
[9] Andreeva, L. A., Nagaeva, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Antiviral properties of structural fragments of the peptide Selank. Doklady Biological Sciences, 431, 79–82. https://doi.org/10.1134/S0012496610020031
[10] Czabak-Garbacz, R., Cygan, B., Wolański, Ł., & Kozlovsky, I. (2006). Influence of long-term treatment with tuftsin analogue TP-7 on anxiety-phobic states and body weight. Pharmacological Reports, 58(4), 562–567. PMID: 16963804.